cell
cultur
infect
vaccinia
viru
number
count
viru
particl
substanti
higher
number
plaqu
obtain
titrat
found
standard
vaccin
prepar
recombin
modifi
vaccinia
viru
ankara
produc
plaqueform
virion
fulli
permiss
cell
cultur
evalu
biolog
activ
nonplaqueform
particl
gener
recombin
virus
express
fluoresc
report
protein
transcript
control
specif
viral
earli
late
promot
live
cell
imag
autom
count
fluoresc
microscopi
indic
virtual
viru
particl
enter
cell
switch
viral
gene
express
although
nonplaqueform
infect
arrest
level
viral
earli
gene
express
detect
activ
late
viral
transcript
singl
infect
cell
thu
nonplaqueform
particl
biolog
activ
like
contribut
immunogen
vaccinia
viru
vaccin
vaccinia
viru
vacv
beststudi
poxviru
prototyp
live
viru
vaccin
use
erad
human
smallpox
review
see
moss
vacv
among
first
anim
virus
cultur
purifi
maitland
maitland
f
parker
nye
rf
parker
river
steinhardt
et
al
earli
studi
viru
prepar
skin
infect
rabbit
smadel
et
al
chorioallantoi
membran
cam
embryon
chicken
egg
dumbel
et
al
alreadi
provid
evid
total
particl
also
call
elementari
bodi
produc
infecti
vacv
virion
inde
ratio
total
particl
plaqueform
unit
pfu
determin
purifi
prepar
vacv
use
protocol
ultracentrifug
sucrosegradi
similar
one
still
use
produc
vaccin
prepar
joklik
singl
studi
use
semipurifi
remov
cellular
debri
viru
harvest
via
lowspe
centrifug
mva
compar
em
count
particl
tissu
cultur
infecti
dose
determin
total
particl
guggenberg
biolog
phenomenon
true
mani
anim
virus
even
disregard
morpholog
biochem
incomplet
virion
million
viru
particl
usual
need
initi
singl
event
infect
isaac
ratio
cam
infect
tissu
cultur
plaqu
vacv
one
highest
ratio
viru
infect
particl
galasso
sharp
joklik
interestingli
earli
experi
suggest
greater
fraction
nonplaqueform
vacv
particl
enter
cell
infecti
tissu
cultur
galasso
sharp
yet
remain
obscur
whether
infect
abl
initi
viru
life
cycl
switch
gene
express
protein
synthesi
furthermor
preval
nonplaqueform
particl
vacv
vaccin
prepar
possibl
influenc
immunogen
vaccin
efficaci
larg
unknown
today
three
decad
erad
smallpox
natur
diseas
vacv
still
need
reserv
vaccin
smallpox
due
threat
bioterror
moss
moreov
viru
success
use
vector
develop
new
vaccin
diseas
mackett
et
al
panicali
paoletti
howev
vacv
vaccin
use
smallpox
erad
campaign
would
current
consid
unsatisfactori
safeti
profil
safer
strain
vacv
modifi
vaccinia
viru
ankara
mva
establish
vaccin
develop
review
see
moss
mva
obtain
extens
serial
passag
vacv
strain
ankara
chicken
embryo
fibroblast
cef
result
dna
delet
mutat
multipl
site
viral
genom
antoin
et
al
mayr
munz
meyer
et
al
mva
lost
abil
product
replic
mammalian
cell
maintain
express
class
viral
recombin
gene
condit
nonpermiss
viral
growth
therefor
mva
serv
except
safe
live
viral
vector
vaccin
sutter
moss
multipl
recombin
mva
current
undergo
clinic
test
vaccin
variou
human
infect
includ
aid
tuberculosi
malaria
review
see
gilbert
gomez
et
al
critic
recent
candid
mva
vaccin
develop
experiment
immun
human
emerg
infect
highli
pathogen
avian
influenza
viru
middl
east
respiratori
syndrom
west
nile
fever
ebola
hemorrhag
fever
ewer
et
al
kreijtz
et
al
volz
et
al
volz
et
al
clinic
use
mva
vector
vaccin
expand
vaccin
prepar
requir
nonclin
character
lot
consist
puriti
infect
recombin
gene
express
experi
other
indic
biolog
properti
purifi
mva
particl
prepar
gener
unknown
fundament
question
pertain
regul
hostrestrict
gene
express
well
practic
question
mva
vaccin
immunogen
also
remain
unclear
studi
recombin
mva
found
nonplaqueform
virion
standard
mva
vaccin
prepar
avian
cell
line
specif
abl
monitor
abil
virion
infect
differ
host
cell
activ
viral
gene
express
use
report
virus
express
fluoresc
protein
control
earli
late
viral
promot
result
singl
cell
infect
synthes
earli
lesser
extent
late
gene
product
comparison
also
analyz
particl
properti
infect
progress
recombin
viru
prepar
base
fulli
replic
compet
parent
vacv
ankara
strain
character
particl
content
standard
mva
vaccin
prepar
select
sucrosecushion
purifi
prepar
mva
candid
vaccin
produc
ebola
viru
glycoprotein
mvaebovgp
obtain
clonal
isol
plaqu
purif
first
obtain
standard
count
total
particl
use
viru
counter
devic
virocyt
viru
counter
known
use
qualiti
control
monitor
vaccin
manufactur
viru
count
base
flow
cytometri
use
two
differ
fluoresc
dye
stain
coloc
protein
nucleic
acid
mvaebovgp
prepar
count
total
viru
particl
vp
ml
fig
comparison
infecti
viru
particl
quantifi
plaqu
titrat
result
plaqueform
unit
pfu
ml
approxim
total
viru
particl
count
viru
prepar
data
line
previou
result
particl
count
electron
microscopi
suggest
consider
fraction
nonplaqueform
particl
present
vacv
prepar
investig
biolog
properti
nonplaqu
form
vacv
particl
detail
construct
recombin
virus
mvagfpmcherri
cvagfpmcherri
report
virus
fig
cvagfpmcherri
serv
directli
compar
mva
fulli
replicationcompet
vacv
use
ankara
strain
true
ancestor
viru
mva
recombin
virus
design
monitor
infect
cycl
visual
key
step
viral
gene
express
detect
synthesi
fluoresc
marker
protein
earli
gfp
product
indic
viru
entri
transcript
viral
earli
gene
detect
red
fluoresc
mcherri
protein
latemcherri
signal
start
dna
synthesi
viral
late
gene
express
virus
qualiti
control
pcr
analysi
confirm
stabl
integr
gfp
encod
sequenc
intergen
site
mcherri
sequenc
delet
site
iii
mva
genom
fig
fig
data
shown
recombin
virus
genet
stabl
test
growth
well
product
recombin
gfp
mcherri
protein
detect
western
blot
analysi
fig
data
shown
expect
mvagfpmcherri
replic
effici
avian
cef
cell
human
hela
hacat
cell
test
activ
report
virus
tissu
cultur
infect
examin
product
fluoresc
protein
gfp
mcherri
chicken
cef
human
cell
hacat
hela
fluoresc
microscopi
fig
h
post
infect
hpi
microscopi
reveal
foci
mvagfpmcherri
infect
cef
cell
red
fluoresc
cell
center
surround
green
fluoresc
cell
mark
earli
late
phase
mva
infect
contrast
hela
hacat
cell
detect
singl
green
red
fluoresc
cell
format
plaqu
foci
fluoresc
cell
product
cvagfpmcherri
infect
result
typic
vacv
plaqu
visibl
hpi
four
cell
cultur
red
latemcherri
produc
cell
accumul
center
larg
viru
plaqu
green
earlygfp
synthesi
found
around
peripheri
plaqu
result
provid
reason
proof
principl
use
recombin
virus
visual
variou
product
abort
infect
event
tissu
cultur
use
standard
sucrosecushion
purifi
prepar
mvagfpmcherri
cvagfpmcherri
determin
total
viru
particl
number
particl
count
measur
infect
plaqu
titrat
fig
agreement
data
analysi
also
reveal
least
total
particl
pfu
detail
viru
counter
measur
record
vpml
mvagfpmcherri
vpml
cvagfpmcherri
contrast
plaqu
form
unit
quantifi
plaqu
titrat
amount
pfuml
total
particl
mvagfpmcherri
pfuml
total
particl
cvagfpmcherri
monitor
infect
event
cell
cultur
permiss
product
viru
replic
analyz
kinet
gfp
mcherri
express
upon
mvagfpmcherri
infect
cef
cell
fig
gfp
mcherri
express
detect
fluoresc
microscopi
mostli
reveal
singl
green
fluoresc
cell
hpi
hpi
singl
green
cell
shift
red
fluoresc
adjac
cell
start
show
green
fluoresc
form
foci
infect
cell
mvagfpmcherri
form
even
rounder
plaqu
cell
plaqu
cef
irregularli
shape
correspond
wellknown
mva
plaqu
phenotyp
cell
cultur
kremer
et
al
hpi
readili
observ
grow
mvagfpmcherri
plaqu
cell
monolay
major
monitor
singl
green
fluoresc
cell
neither
chang
red
fluoresc
develop
new
viru
plaqu
hpi
time
point
hpi
seem
suitabl
determin
ratio
singl
infect
cell
viru
plaqu
cef
mvagfpmcherri
infect
fig
singl
fluoresc
cell
viru
plaqu
cell
monolay
automat
quantifi
keyenc
hybrid
cell
count
modul
chicken
cell
cultur
detect
fluoresc
event
identifi
viral
plaqu
howev
infect
event
detect
singl
fluoresc
cell
imag
fix
infect
cell
cultur
perform
standard
vacvspecif
immunostain
assay
confirm
data
plaqu
count
use
hybrid
cell
count
analysi
assay
equal
number
similar
pattern
viru
plaqu
detect
fig
result
indic
surprisingli
high
number
singl
cell
infect
event
close
correl
calcul
number
nonplaqu
form
particl
mvagfpmcherri
prepar
precis
follow
outcom
mvagfpcherri
infect
cef
hela
cell
grown
plate
select
singl
gfp
posit
cell
hpi
automat
monitor
select
infect
cell
monolay
via
live
cell
imag
keyenc
time
laps
modul
time
period
h
fig
cell
select
singl
infect
green
fluoresc
cell
result
format
plaqu
singl
cell
proceed
late
gene
express
indic
red
fluoresc
infect
cell
remain
green
ie
earli
gene
express
could
confirm
find
cef
cell
select
cell
form
plaqu
shift
red
fluoresc
without
plaqu
develop
remain
singl
green
fluoresc
cell
expect
mvagfpmcherri
infect
human
hela
cell
result
detect
viru
plaqu
howev
overal
ratio
infect
green
cell
arrest
earli
stage
gene
express
infect
red
cell
exhibit
late
gene
express
similar
proport
observ
avian
cell
cultur
fig
next
analyz
infect
replicationcompet
cvagfpmcherri
hela
cell
use
experiment
set
fig
monolay
select
singl
infect
cell
develop
typic
plaqu
singl
cell
display
red
fluoresc
without
format
plaqu
infect
cell
remain
green
result
compar
obtain
mvagfpmcherri
cell
cultur
interestingli
hela
cell
replicationcompet
cvagfpmcherri
form
threefold
plaqu
seen
cell
infect
overal
data
demonstr
tissu
cultur
mva
cva
infect
event
remain
arrest
level
viral
earli
gene
express
test
composit
biolog
activ
viru
particl
present
standard
mva
vaccin
prepar
first
time
use
new
report
virus
express
fluoresc
marker
gfp
mcherri
control
earli
late
viral
promot
past
year
vacv
biolog
greatli
benefit
advanc
genet
engin
fluoresc
imag
techniqu
recombin
virus
fluoresc
tag
viral
protein
elegantli
use
elucid
celltocel
spread
intracellular
movement
vacv
particl
frischknecht
et
al
hollinshead
et
al
ward
moss
addit
fluoresc
report
virus
serv
screen
experi
antivir
drug
dal
pozzo
et
al
report
virus
success
monitor
vacv
infect
progress
plaqueform
nonplaqueform
virion
identifi
activ
transcript
viral
earli
late
gene
infect
research
recombin
mva
virus
serv
candid
vaccin
compat
clinic
use
industrialscal
product
review
see
volz
adv
viru
re
press
data
qualiti
requir
initi
clinic
trial
includ
evalu
phenotyp
properti
vaccin
viru
prepar
european
medicin
agenc
guidelin
qualiti
nonclin
clinic
aspect
live
recombin
viral
vector
vaccin
sucrosegradi
purifi
prepar
convent
vacv
known
compris
total
particl
infecti
particl
eg
count
electron
microscopi
measur
plaqu
test
joklik
also
studi
use
industrystandard
viru
counter
regular
protocol
mva
titrat
kremer
et
al
found
major
nonplaqueform
virion
standard
mva
vaccin
sucrosecushion
purifi
prepar
cef
cell
avian
cell
line
consist
use
mva
amplifi
purifi
normal
titer
cell
cultur
similar
noninfecti
particl
found
mani
mammalian
virus
biolog
activ
associ
particl
larg
ignor
marcu
et
al
pierson
diamond
character
nonplaqueform
particl
mva
vector
vaccin
prepar
seem
relev
due
potenti
role
induc
innat
adapt
immun
respons
lopez
test
sucrosecushion
purifi
prepar
mvagfpmcherri
cvagfpmcherri
tissu
cultur
infect
detect
unexpectedli
high
number
singl
fluoresc
cell
monitor
infect
event
show
nonplaqueform
particl
also
activ
viral
gene
express
although
singl
cell
infect
restrict
synthes
earli
gene
product
de
novo
synthesi
earli
viral
rna
suggest
nonplaqu
form
infect
trigger
innat
immun
signal
previous
describ
nfkb
activ
follow
vacv
earli
transcript
martin
shisler
willi
et
al
notabl
time
laps
experi
allow
us
precis
follow
develop
singl
viral
plaqu
fate
singl
infect
cell
observ
synthesi
gfp
mcherri
see
video
clip
regardless
stage
viral
gene
express
earli
late
permiss
product
infect
mani
remain
singl
fluoresc
cell
underw
morpholog
chang
includ
phase
contract
retract
cell
project
follow
cell
round
membran
bleb
disintegr
detach
cell
monolay
sinc
result
experi
replicationcompet
cvagfpmcherri
confirm
data
seen
mvagfpmcherri
confid
gener
valid
find
infect
particl
differ
strain
vacv
possibl
infect
virion
orthopoxvirus
mechanist
reason
substanti
portion
abort
infect
event
still
remain
unclear
one
possibl
vacv
prepar
commonli
contain
fraction
defect
virion
unabl
initi
full
cycl
viral
gene
express
product
viru
replic
examin
viru
particl
stock
prepar
electron
microscopi
detect
matur
brickshap
virion
normal
morpholog
data
shown
yet
appar
absenc
malform
particl
formal
exclud
possibl
mutat
block
later
stage
infect
altern
biolog
host
cell
essenti
replic
vacv
tempt
specul
simpli
condit
infect
host
cell
determin
outcom
infect
activ
host
cell
signal
pathway
eg
involv
mapk
mitogenactiv
protein
kinas
erk
extracellular
signalregul
kinas
jnk
jun
ntermin
kinas
shown
critic
product
infect
vacv
spread
andrad
et
al
de
magalha
et
al
f
wang
et
al
moreov
activ
host
signal
pathway
specif
modul
favor
viru
replic
variou
poxviru
regulatori
protein
de
magalha
et
al
schwenek
et
al
torr
et
al
g
wang
et
al
find
use
develop
oncolyt
poxvirus
better
grow
tumor
cell
pathway
malignantli
activ
bell
mcfadden
observ
cvagfpmcherri
infect
result
enhanc
plaqu
format
hela
cell
might
base
preferenti
product
replic
viru
tumor
cell
see
fig
two
major
infecti
form
vacv
particl
matur
virion
mv
extracellular
envelop
virion
ev
moss
mv
infecti
virion
surround
lipoprotein
membran
accumul
within
cytoplasm
vacv
infect
cell
condit
et
al
sinc
mv
abund
virion
form
present
vaccin
prepar
data
obtain
experi
might
essenti
qualiti
control
mva
base
vaccin
infecti
form
mv
ev
distinct
biolog
properti
activ
ev
respons
effici
celltocel
spread
contribut
transmiss
within
host
mv
play
key
role
transmiss
host
anim
blasco
moss
cudmor
et
al
moss
experi
need
clarifi
possibl
distinct
role
ev
infect
gene
express
plaqu
format
differ
host
cell
substrat
conclus
experi
confirm
infect
nonplaqueform
particl
vacv
result
gene
express
despit
inabl
defect
viru
particl
induc
plaqu
format
particl
still
abl
switch
earli
gene
express
interestingli
alreadi
earli
work
galasso
sharp
suggest
nonrepl
vacv
particl
enter
cell
exert
biolog
activ
recent
uvinactiv
recombin
vacv
use
express
earli
gene
nonrepl
vector
tumor
immunotherapi
zajac
et
al
thu
viral
recombin
earli
transcript
might
serv
effici
trigger
innat
immun
respons
antigen
product
recombin
vaccin
similar
process
describ
vaccineinduc
activ
immun
addit
find
indic
choic
earli
earlyl
promot
appropri
approach
practic
activ
vaccineinduc
immun
final
result
support
abil
mvabas
vaccin
stimul
balanc
interplay
innat
adapt
immun
key
robust
protect
select
pathogen
hacat
jena
cell
cultur
vle
dulbecco
mem
biochrom
gmbh
supplement
heat
inactiv
fetal
bovin
serum
hifb
sigma
penicillinstreptomycin
sigma
hepesbuff
sigma
hela
cell
maintain
minimum
essenti
medium
eagl
mem
sigma
contain
hifb
antibiot
describ
primari
chicken
embryo
fibroblast
cef
prepar
chicken
embryo
spf
egg
valo
cuxhaven
subsequ
grown
mem
supplement
penicillinstreptomycin
mem
nonessenti
amino
acid
solut
sigma
hifb
cell
maintain
atmospher
recombin
mvagfpmcherri
gener
homolog
recombin
describ
previous
kremer
et
al
mva
meyer
et
al
pvgf
insert
site
viral
genom
pvgf
underlin
indic
transcript
start
site
describ
broyl
et
al
natur
vaccinia
viru
promot
control
earli
express
vacv
orf
mrna
recent
report
belong
tempor
first
class
earli
gene
immediateearli
class
subclust
assarsson
et
al
yang
et
al
plasmid
piiigptex
serv
vector
insert
mcherri
place
vaccinia
viru
promot
delet
iii
recombin
mva
obtain
clonal
isol
plaqu
purif
use
five
eight
passag
cef
follow
plasmid
transfect
final
recombin
virus
amplifi
cef
screen
express
fluoresc
protein
use
identifi
isol
recombin
virus
qualiti
control
experi
perform
use
standard
methodolog
kremer
et
al
genet
ident
genet
stabil
report
viru
assess
via
pcr
analysi
genom
viral
dna
replic
capac
recombin
viru
confirm
onestep
multiplestep
growth
experi
cef
hela
hacat
cell
cvagfpmcherri
construct
similar
manner
mvagfpmcherri
fulli
replicationcompet
viru
waibler
et
al
use
parent
viru
propag
carri
cell
direct
ancestor
viru
mva
genom
sequenc
ident
mva
insert
site
delet
iii
sucrosecushion
purifi
viru
stock
mvagfpmcherri
cvagfpmcherri
gener
ultracentrifug
sucros
cushion
follow
resuspens
mm
tri
buffer
ph
use
standard
procedur
describ
kremer
et
al
joklik
viral
plaqu
form
unit
pfu
determin
via
standard
plaqu
assay
describ
kremer
cowork
kremer
et
al
briefli
confluent
cef
cell
monolay
plate
infect
serial
dilut
virus
h
incub
cell
wash
phosphat
buffer
salin
pb
incub
fresh
medium
contain
hifb
two
day
follow
vaccinia
specif
immunostain
infect
cell
fix
acetonemethanol
min
wash
pb
incub
min
polyclon
rabbit
antivaccinia
viru
antibodi
addit
wash
step
pb
cell
incub
peroxidaseconjug
affinipur
goat
antirabbit
secondari
antibodi
min
plaqu
visual
use
trueblu
peroxidas
substrat
solut
kpl
count
calcul
describ
previous
kremer
et
al
viru
titrat
perform
duplic
repeat
least
three
time
total
viru
particl
estim
use
virocyt
viruscount
follow
manufactur
instruct
virocyt
bloomfield
co
briefli
sucrosecushion
purifi
viru
sampl
dilut
virocyt
sampl
dilut
buffer
subsequ
ml
sampl
incub
ml
combo
dye
solut
combin
two
fluoresc
dye
specif
protein
nucleic
acid
stoffel
et
al
min
lightprotect
incub
room
temperatur
viru
particl
quantifi
viru
counter
simultan
detect
fluoresc
signal
use
viru
counter
dual
channel
flow
cytomet
measur
one
viru
particl
intersampl
wash
follow
cleanli
control
run
perform
sampl
analysi
medium
uninfect
cef
use
neg
control
total
viru
particl
concentr
record
viru
particl
per
ml
vpml
determin
least
three
time
per
viru
sampl
fluoresc
imag
obtain
use
invert
fluoresc
microscop
keyenc
plan
fluor
na
object
zsection
set
emiss
gfp
filter
excit
wavelength
nm
absorpt
wavelength
nm
texasr
filter
excit
wavelength
nm
absorpt
wavelength
nm
use
detect
green
red
fluoresc
raw
imag
data
process
analyz
bzx
analyz
softwar
ratio
singl
infect
fluoresc
cell
plaqueform
fluoresc
unit
assess
mvagfpmcherri
infect
permiss
cell
cultur
cef
cell
plate
well
infect
moi
receiv
ml
inoculum
min
incub
cold
start
cell
wash
pb
three
time
incub
ml
fresh
medium
contain
hifb
h
infect
multipl
fluoresc
brightfield
imag
infect
well
acquir
use
object
stitch
togeth
via
keyenc
merg
function
afterward
vaccinia
specif
immunostain
captur
well
perform
describ
plaqu
assay
brightfield
imag
well
serv
control
total
singl
fluoresc
cell
count
quantifi
use
singl
extract
function
hybrid
cell
count
softwar
keyenc
hybrid
cell
count
modul
total
foci
count
manual
live
cell
imag
cef
hela
cell
cultur
plate
infect
sucrosecushion
purifi
viral
stock
prepar
mvagfpmcherri
sucrosecushion
purifi
viral
stock
prepar
cvagfpmcherri
moi
via
cold
start
describ
three
wash
step
pb
ml
fresh
medium
contain
fb
ad
cell
incub
hpi
singl
green
fluoresc
cell
select
separ
experi
develop
singl
infect
cell
observ
min
increment
h
use
keyenc
time
laps
modul
time
laps
analysi
perform
co
concentr
use
incub
chamber
tokai
hit
incub
system
microscop
allow
h
record
time
laps
experi
recombin
mva
cva
virus
perform
least
three
time
chicken
embryo
fibroblast
infect
moi
mvagfpmcherri
cvagfpmcherri
absenc
presenc
cytosin
arabinosid
arac
mgml
mva
wild
type
mockinfect
cell
serv
control
total
cell
extract
prepar
separ
sdspage
protein
analyz
via
western
blot
use
antigfp
rabbit
fraction
antibodi
life
technolog
antimcherri
rat
fraction
antibodi
kindli
provid
elisabeth
kremmer
helmholtz
zentrum
dilut
primari
antibodi
detect
gfp
mcherri
via
microchemisystem
biostep
antirabbit
hrpconjug
antibodi
sigma
dilut
goat
antirat
hrpconjug
antibodi
biolegend
use
secondari
antibodi
differ
viru
particl
titr
assess
statist
signific
graphpad
prism
version
softwar
graphpad
softwar
san
diego
usa
use
mannwhitney
u
test
pvalu
less
consid
statist
signific
